Skip to content
PaperFren

Are there molecular subtypes of Alzheimer brains?

Open paper intelligence

Brain multi-omics integration found four multimodal AD profiles, including severe Knight-C4 with worse cognition and heavy molecular dysregulation.

Source

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease

Eteleeb AM, Novotny BC, Tarraga CS, et al. · PLoS biology · 2024

doi.org/10.1371/journal.pbio.3002607Read the full paper ↗58 citationscc by

Study at a glance

Design
Computational / modelling — Multi-cohort brain multi-omics ML clustering of AD molecular profiles
N
N=42 · Knight-C4 high-dysregulation cluster n=42 within four multimodal profiles
Population
Human AD brain cohorts with multi-omic + clinical/neuropath data
Outcome
Multimodal molecular clusters linked to cognition and progression

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Are there molecular subtypes of Alzheimer brains?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

Four multimodal profiles.

We discovered 4 unique multimodal molecular profiles, one of them showing signs of poor cognitive function, a faster pace of disease progression, shorter survival with the disease, severe neurodegeneration and astrogliosis, and reduced levels of metabolomic profiles.

Knight-C4 n=42.

We identified 4 clusters ( Fig 2A ) in which the molecular profiles of Cluster4 (named Knight-C4 hereafter, n = 42) exhibited a pronounced dysregulation of genes, proteins, and metabolites.
Read passages in the original paper

What they did

Integrated transcriptomic, proteomic, metabolomic, and lipidomic profiles with clinical/neuropathological data using machine learning and clustered multimodal profiles.

What they found

Four profiles emerged; one severe profile had poor cognition, faster progression, shorter survival, neurodegeneration/astrogliosis, and reduced metabolomic signals. Knight-C4 (n=42) showed pronounced multi-layer dysregulation.

The limits

What it doesn't show

Clusters are observational patterns, not proven treatment-response groups.

Key terms

Multi-omics
Combined transcriptome, proteome, metabolome, and lipidome.
Multimodal cluster
Group defined across several molecular layers.
Knight-C4
High-dysregulation cluster (n=42).
Astrogliosis
Reactive astrocyte response in neurodegeneration.
Cross-omics
Joint analysis across omic layers.
Disease progression
Pace of clinical/neuropathological worsening.

Flashcards

1 / 8

0 of 8 answers reviewed

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

Profiles found:

Common questions

Profiles found?

Four.

Knight-C4 n?

42.

Layers?

Transcriptome/proteome/metabolome/lipidome + clinical.

Severe features?

Worse cognition, faster course, shorter survival.

More on Gene expression